ArticleJournal of primary care & community health
Hesitancy Toward the First COVID-19 Vaccine Booster Dose: A Cross-Sectional Study in Morocco.
Article in Journal of primary care & community health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe COVID-19 pandemic has posed significant global health challenges, requiring mass vaccination to reduce severe illness and mortality. Despite strong evidence supporting booster dose safety and efficacy, uptake remains low due to widespread hesitancy. This study aims to comprehensively explore the factors contributing to first COVID-19 booster vaccine hesitancy among the general population in Morocco.
methodsA cross-sectional study was conducted among 574 participants from primary healthcare centers in Fez, Morocco, between April 2022 and April 2023. Data were collected using a structured questionnaire based on the WHO SAGE framework, assessing socio-demographic, contextual, individual, group, and vaccine-specific determinants. Statistical analyses included chi-squared tests and multivariate logistic regression (
resultsHesitancy toward the first booster dose was reported by 66.2% of participants. Vaccine-specific concerns were the strongest predictor (Adjusted Odds Ratio [AOR] = 27.6; 95% Confidence Interval [CI] = [11.1-68.3];
conclusionBooster dose hesitancy in Morocco is driven by vaccine-specific concerns, contextual influences, and individual beliefs. Addressing these factors through targeted communication, trust-building strategies, and inclusive public health policies is essential to increase booster uptake and strengthen national pandemic response efforts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.